LONDON--(BUSINESS WIRE)--Evariste, a TechBio using mathematics and AI to design small molecule therapeutics, has entered into a preclinical research agreement with Orion Corporation, a leading ...
Evariste is a TechBio using mathematics and AI to develop small molecule therapeutics for oncology. Their AI-powered platform, Frobenius, identifies novel targets and biomarkers and designs drug ...